123 related articles for article (PubMed ID: 20636430)
1. Bordetella parapertussis isolates not expressing pertactin circulating in France.
Bouchez V; Brun D; Dore G; Njamkepo E; Guiso N
Clin Microbiol Infect; 2011 May; 17(5):675-82. PubMed ID: 20636430
[TBL] [Abstract][Full Text] [Related]
2. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
3. PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population.
Mäkinen J; Mertsola J; Soini H; Arvilommi H; Viljanen MK; Guiso N; He Q
J Med Microbiol; 2003 Dec; 52(Pt 12):1059-1063. PubMed ID: 14614063
[TBL] [Abstract][Full Text] [Related]
4. Molecular typing of Bordetella parapertussis isolates circulating in Pakistan.
Bokhari H; Said F; Syed MA; Mughal A; Kazi YF; Kallonen T; He Q; King AJ; Heuvelman K; Mooi FR
FEMS Immunol Med Microbiol; 2011 Dec; 63(3):373-80. PubMed ID: 22092564
[TBL] [Abstract][Full Text] [Related]
5. Adaptive evolution of the Bordetella autotransporter pertactin.
Diavatopoulos DA; Hijnen M; Mooi FR
J Evol Biol; 2006 Nov; 19(6):1931-8. PubMed ID: 17040390
[TBL] [Abstract][Full Text] [Related]
6. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
[TBL] [Abstract][Full Text] [Related]
9. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
Bouchez V; Brun D; Cantinelli T; Dore G; Njamkepo E; Guiso N
Vaccine; 2009 Oct; 27(43):6034-41. PubMed ID: 19666155
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica.
Boursaux-Eude C; Guiso N
Infect Immun; 2000 Aug; 68(8):4815-7. PubMed ID: 10899896
[TBL] [Abstract][Full Text] [Related]
11. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
[TBL] [Abstract][Full Text] [Related]
12. P.70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli.
Li LJ; Dougan G; Novotny P; Charles IG
Mol Microbiol; 1991 Feb; 5(2):409-17. PubMed ID: 2041476
[TBL] [Abstract][Full Text] [Related]
13. The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli.
Hijnen M; van Gageldonk PG; Berbers GA; van Woerkom T; Mooi FR
Protein Expr Purif; 2005 May; 41(1):106-12. PubMed ID: 15802227
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.
Hegerle N; Rayat L; Dore G; Zidane N; Bedouelle H; Guiso N
Microbes Infect; 2013 May; 15(5):399-408. PubMed ID: 23470234
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis.
Souder E; Vodzak J; Evangelista AT; Long SS
Pediatr Infect Dis J; 2017 Jan; 36(1):119-121. PubMed ID: 27956730
[TBL] [Abstract][Full Text] [Related]
17. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
18. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
19. Pertussis Resurgence Associated with Pertactin-Deficient and Genetically Divergent Bordetella Pertussis Isolates in Israel.
Bamberger E; Abu Raya B; Cohen L; Golan-Shany O; Davidson S; Geffen Y; Srugo I
Pediatr Infect Dis J; 2015 Aug; 34(8):898-900. PubMed ID: 25966915
[TBL] [Abstract][Full Text] [Related]
20. Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.
Hiramatsu Y; Miyaji Y; Otsuka N; Arakawa Y; Shibayama K; Kamachi K
Emerg Infect Dis; 2017 Apr; 23(4):699-701. PubMed ID: 28322702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
